The unifying theme of this application is the incidence of multiple chronic conditions (MCC) and its mechanisms and health outcomes. In the United States, about 62% of Medicare recipients ages 65 to 74 years have MCC (= 2 chronic conditions), and the frequency increases dramatically to 82% above age 85. Because adults with MCC are at increased risk of functional decline and are particularly vulnerable to poor care, MCC threatens both the public and financial health of the United States. MCC prevalence may be reduced by delaying the onset of single conditions and combinations of conditions through modification of risk factors or determinants of diseases. However, current preventive efforts have partly failed because they have focused on one disease at a time and too late in life. For this reason, there is a critical need to identify groups of individuals at risk earlier in life, an to develop interventions to prevent MCC and its adverse health outcomes. These priorities were outlined in the Multiple Chronic Conditions Strategic Framework of the US Department of Health and Human Services (DHHS) of 2010. The DHHS also developed a list of 20 conditions considered a public health priority for the nation. Although data are available about the prevalence of MCC in the United States and worldwide, the incidence of MCC and its epidemiologic mechanisms and health outcomes remain poorly understood. The Rochester Epidemiology Project (REP) is an ideal environment to study the incidence of MCC because it includes information for all ages from newborns to death, regardless of insurance status or health care setting (both inpatient and outpatient care), and encompasses the full spectrum of care, from primary to tertiary care. In this renewal application, we propose to study the mechanisms of development of incident MCC for specific physical and mental health conditions across all ages (Aim 1), and to identify short-term and long-term health outcomes of incident MCC dyads (Aim 2). This knowledge will inform earlier and more integrated interventions to prevent MCC and to improve its outcomes at the local community level and at the national level, as recommended by the DHHS and other federal agencies. Finally, we will develop an innovative approach to share REP data and our MCC findings to inform research and practice (Aim 3). Broad sharing of the comprehensive and longitudinal REP data both locally and to the wider scientific, clinical, and public health community will allow investigators and practitioners worldwide to rapidly explore patterns of diseases, procedures, drug prescriptions, MCC, and their associations at no cost. In summary, the studies proposed here are novel, can be efficiently conducted using the REP, and are urgently needed.

Public Health Relevance

We propose to study the mechanisms and the health outcomes of newly developed multiple chronic conditions using the records-linkage system of the unique Rochester Epidemiology Project, which has captured comprehensive information about the medical care delivered to local residents since the 1960s. Our ultimate goal is to provide evidence to guide the prevention of multiple chronic conditions, and to improve health outcomes for those already affected. The studies proposed here are novel, can be efficiently conducted using the Rochester Epidemiology Project, and are urgently needed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG034676-50A1
Application #
8960156
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Dutta, Chhanda
Project Start
2010-07-01
Project End
2020-05-31
Budget Start
2015-09-30
Budget End
2016-05-31
Support Year
50
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kyle, Robert A; Larson, Dirk R; McPhail, Ellen D et al. (2018) Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review. Mayo Clin Proc 93:739-746
Krell-Roesch, Janina; Feder, Nathanael T; Roberts, Rosebud O et al. (2018) Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging. J Alzheimers Dis 63:149-155
Wessman, Laurel L; Andersen, Louise K; Davis, Mark D P (2018) Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide. Int J Dermatol 57:1021-1034
Aniwan, Satimai; Tremaine, William J; Raffals, Laura E et al. (2018) Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study. J Crohns Colitis 12:137-144
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131
Mundell, Benjamin F; Luetmer, Marianne T; Kremers, Hilal Maradit et al. (2018) The risk of major cardiovascular events for adults with transfemoral amputation. J Neuroeng Rehabil 15:58
Savica, Rodolfo; Grossardt, Brandon R; Rocca, Walter A et al. (2018) Parkinson disease with and without Dementia: A prevalence study and future projections. Mov Disord 33:537-543
Kittanamongkolchai, Wonngarm; Vaughan, Lisa E; Enders, Felicity T et al. (2018) The Changing Incidence and Presentation of Urinary Stones Over 3 Decades. Mayo Clin Proc 93:291-299
Bothun, Erick D; Cavalcante, Lilian C B; Hodge, David O et al. (2018) Population-based Incidence of Intraocular Lens Exchange in Olmsted County, Minnesota. Am J Ophthalmol 187:80-86
Maciel, Gabriel; Servioli, Luisa; Nannini, Carlotta et al. (2018) Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016. RMD Open 4:e000575

Showing the most recent 10 out of 881 publications